E
Eric J. Topol
Researcher at Scripps Health
Publications - 1406
Citations - 162373
Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Adapting to Artificial Intelligence: Radiologists and Pathologists as Information Specialists.
Saurabh Jha,Eric J. Topol +1 more
TL;DR: In 1960, Lusted predicted an electronic scannercomputer to examine chest photofluorograms, to separate the clearly normal chest films from the abnormal chest films, and nearly 60 years after Lusted’s prediction, Enlitic, a technology company in Silicon Valley, inputted images of normal radiographs and radiographs with fractures into a computerized database.
Journal ArticleDOI
Scientific and therapeutic advances in antiplatelet therapy.
Deepak L. Bhatt,Eric J. Topol +1 more
TL;DR: It is now evident that the platelet is in fact a key mediator of thrombosis as well as of inflammation, and new insights at the cellular and genomic levels will probably generate novel drugs to inhibit platelet function more effectively and safely than previously possible.
Journal ArticleDOI
Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease.
Killian Robinson,Ellen L. Mayer,Dave P. Miller,Ralph Green,Frederick Van Lente,Anjan Gupta,Kandice Kottke-Marchant,Susan R. Savon,Jacob Selhub,Steven E. Nissen,Michael Kutner,Eric J. Topol,Donald W. Jacobsen +12 more
TL;DR: Within the range currently considered to be normal, the risk for coronary disease rises with increasing plasma homocysteine regardless of age and sex, with no threshold effect.
Journal ArticleDOI
Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction
Koon-Hou Mak,David J. Moliterno,Christopher B. Granger,Dave P. Miller,Harvey D. White,Robert G. Wilcox,Robert M. Califf,Eric J. Topol +7 more
TL;DR: In this paper, the authors characterized the contemporary relation between diabetes and outcome after myocardial infarction treated with thrombolytic agents from a large international cohort and found that patients with diabetes alone and in association with its comorbidities, portends a substantially worse 30-day and 1-year prognosis for patients with myocardious infarctions.
Journal ArticleDOI
Cell adhesion molecules in coronary artery disease
TL;DR: This review focuses on providing the clinically relevant biology of these families of adhesion molecules, setting the foundation for delineation of their emerging role in cardiovascular therapeutics.